Results for tag: "Whim Syndrome Drug"

The Whim Syndrome Drug market is a subset of the Immune Disorders Drugs market. It is composed of drugs used to treat Whim Syndrome, a rare, genetic disorder characterized by recurrent infections, skin lesions, and autoimmunity. These drugs are used to reduce the severity of symptoms and improve the quality of life for those affected by the disorder. The Whim Syndrome Drug market is composed of both generic and branded drugs. Generic drugs are typically cheaper than branded drugs, but may not be as effective. Branded drugs are typically more expensive, but may be more effective in treating the disorder. Some companies in the Whim Syndrome Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more